Sign in

CIK 0001490978

  • Large accelerated filer

Schrodinger, Inc.

Sign in to watch
Ticker
SDGR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
954284541
Phone
+1 503-299-1150
Business address
1540 BROADWAY, 24TH FLOOR, NEW YORK, NY, 10036
  1. 4 Planned sale EVP & CFO sold 1,631 shares at $12.90 ($21,033)
  2. 4 Planned sale EVP, CLO & CPO sold 1,094 shares at $12.90 ($14,107)
  3. 4 Planned sale President & CEO sold 3,661 shares at $12.91 ($47,249)
  4. 4 Planned sale See Remarks sold 1,366 shares at $12.90 ($17,625)
  5. 4 Planned sale EVP, CTO & COO, Software sold 1,222 shares at $12.90 ($15,761)
  6. 4 Planned sale See Remarks sold 1,300 shares at $12.81 ($16,653)
  7. 4 Option exercise Director acquired 160,527 shares (option exercise)
  8. 4 Planned sale President & CEO sold 5,560 shares at $11.90 ($66,151)
  9. 4 Grant or award EVP & CFO acquired 17,130 shares (grant or award)
  10. 4 Grant or award EVP, CLO & CPO acquired 30,918 shares (grant or award)
  11. 4 Grant or award EVP, CTO & COO, Software acquired 37,812 shares (grant or award)
  12. 4 Grant or award CAO acquired 9,590 shares (grant or award)
  13. 4 Planned sale See Remarks sold 2,206 shares at $11.99 ($26,454)
  14. 4 Grant or award See Remarks acquired 17,130 shares (grant or award)
  15. 4 Grant or award See Remarks acquired 37,812 shares (grant or award)
  16. 4 Planned sale EVP, CLO & CPO sold 776 shares at $13.80 ($10,705)
  17. 4 Planned sale EVP, CTO & COO, Software sold 925 shares at $13.73 ($12,704)
  18. 4 Planned sale CAO sold 752 shares at $13.79 ($10,370)
  19. 4 Planned sale See Remarks sold 1,230 shares at $13.51 ($16,617)
  20. 4 Planned sale Chief Medical Officer sold 1,395 shares at $21.07 ($29,387)

Page 2 of 17 · 326 filings